This essay analyzes the subject positioning demanded by randomized control trials (RCT). Taking seriously the fact that people in late-stage cancer treatments will die, even if one arm of the study receives a “successful” treatment, Jain argues that the RCT framework carries a politics belied by its status as an objective research method.

The text of this article is only available as a PDF.
You do not currently have access to this content.